# Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life

> **NCT04380597** · — · COMPLETED · sponsor: **Angeles Florez** · enrollment: 10 (actual)

## Conditions studied

- Nail Psoriasis

## Interventions

- **DRUG:** Calcipotriene and betamethasone dipropionate aerosol foam

## Key facts

- **NCT ID:** NCT04380597
- **Lead sponsor:** Angeles Florez
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-26
- **Primary completion:** 2019-12-15
- **Final completion:** 2021-07-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04380597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04380597, "Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04380597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*